CymitQuimica logo

CAS 37854-59-4

:

7,10-dimethyl-2,4-dioxo-benzo[g]pteridine-8-carbaldehyde

Description:
7,10-Dimethyl-2,4-dioxo-benzo[g]pteridine-8-carbaldehyde is a complex organic compound belonging to the pteridine family, characterized by its bicyclic structure that includes a fused aromatic system. This compound features two carbonyl groups (dioxo) and an aldehyde functional group, which contribute to its reactivity and potential applications in organic synthesis and medicinal chemistry. The presence of methyl groups at the 7 and 10 positions enhances its lipophilicity, potentially influencing its biological activity and solubility. The compound's structure suggests it may exhibit interesting optical properties, making it a candidate for studies in photochemistry or as a dye. Additionally, the pteridine core is known for its role in various biological processes, including its involvement in the synthesis of nucleotides and coenzymes. Overall, 7,10-dimethyl-2,4-dioxo-benzo[g]pteridine-8-carbaldehyde is a noteworthy compound for research in both synthetic and applied chemistry contexts.
Formula:C13H10N4O3
InChI:InChI=1/C13H10N4O3/c1-6-3-8-9(4-7(6)5-18)17(2)11-10(14-8)12(19)16-13(20)15-11/h3-5H,1-2H3,(H,16,19,20)
SMILES:Cc1cc2c(cc1C=O)n(C)c1c(c(nc(=O)n1)O)n2
Synonyms:
  • Benzo[g]pteridine-8-carboxaldehyde, 2,3,4,10-tetrahydro-7,10-dimethyl-2,4-dioxo-
  • RO 08-2750
  • 7,10-DIMETHYL-2,4-DIOXOBENZO[G]PTERIDINE-8-CARBALDEHYDE
  • 2,3,4,10-Tetrahydro-7,10-dimethyl-2,4-dioxobenzo[g]pteridine-8-carboxaldehyde
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • Ro 08-2750

    CAS:
    Ro 08-2750
    Purity:≥95%
    Molecular weight:270.24g/mol

    Ref: 54-BUP16346

    5mg
    98.00€
    10mg
    147.00€
  • Ro 08-2750

    Controlled Product
    CAS:
    Formula:C13H10N4O3
    Color and Shape:Neat
    Molecular weight:270.243

    Ref: TR-R700898

    100mg
    10,511.00€
  • Ro 08-2750

    CAS:
    <p>Ro 08-2750 is a potent anti-tumor agent that inhibits the growth of cancer cells. It is structurally similar to a natural compound, largazole, which has been shown to inhibit prostate cancer cell proliferation. Ro 08-2750 may be useful for the treatment of prostate cancer and other cancers with glucocorticoid receptors. The drug also inhibits the production of proinflammatory prostaglandins and shows potent antitumor activity in both cell culture and animal models. Ro 08-2750 binds to the enzyme p-nitrophenyl phosphate (PNPP) and inhibits its activity, inhibiting DNA synthesis by blocking polymerase chain reaction (PCR). The binding affinity between Ro 08-2750 and PNPP is increased by cofactors such as ATP, making it more effective at inhibiting DNA synthesis.</p>
    Formula:C13H10N4O3
    Purity:Min. 95%
    Molecular weight:270.24 g/mol

    Ref: 3D-MBA85459

    10mg
    994.00€
    25mg
    1,527.00€
    50mg
    2,379.00€
  • Ro 08-2750

    CAS:
    Ro 08-2750: A non-peptide NGF inhibitor binding NGF (~1 µM IC50) & selectively inhibits p75NTR over TRKA and MSI RNA-binding (2.7 µM IC50).
    Formula:C13H10N4O3
    Purity:98.795%
    Color and Shape:Solid
    Molecular weight:270.24

    Ref: TM-T16766

    5mg
    67.00€
    10mg
    96.00€
    1mL*10mM (DMSO)
    74.00€